શરેખાન

#SharekhanFNA #SharekhanResearch downgrades #ShilpaMedicare to Hold (PT Rs540) #Q4FY21 was weak qtr & result missed… https://t.co/P3AiruKcZW #SharekhanFNA #SharekhanResearch #ShilpaMedicare #Q4FY21

#SharekhanResearch retain Buy on KEI Inds. with revised PT of Rs750, Descent #Q4FY21 despite challenges, Mgmt expec… https://t.co/n2qitkHvuz #SharekhanResearch #Q4FY21

#SharekhanFNA #SharekhanResearch retains Buy rating on #Aurobindo (PT Rs1185) #Q4FY21 was a weak qtr; US & Europe w… https://t.co/pGlvcfG2s3 #SharekhanFNA #SharekhanResearch #Aurobindo #Q4FY21

#SharekhanFNA #SharekhanResearch retains Buy rating on #IPCA (PT Rs 2560) #Q4FY21 was a strong qtr but PAT missed e… https://t.co/EwwevgHyPg #SharekhanFNA #SharekhanResearch #IPCA #Q4FY21

#SharekhanFNA #SharekhanResearch retains Buy rating on #Divis (PT Rs 4810) #Q4FY21 was a strong qtr with results ah… https://t.co/V7jNzDQowx #SharekhanFNA #SharekhanResearch #Divis #Q4FY21

#SharekhanResearch retain Buy on Dixon Technologies with revised PT of Rs4800, Mixed #Q4FY21 with revenues better t… https://t.co/wKQzyANpgP #SharekhanResearch #Q4FY21

#SharekhanResearch retain Buy on V-Guard with unchanged PT of Rs 311 considering improving business Healthy #Q4FY21… https://t.co/UXSZ2RxzHs #SharekhanResearch #Q4FY21

#SharekhanResearch retain Buy on Cummins India with unchanged PT of Rs1030, Mixed #Q4FY21 performance, Management o… https://t.co/neFTubtx4t #SharekhanResearch #Q4FY21

#SharekhanFNA #SharekhanResearch retains Buy rating on #Cadila (PT Rs 720) reports healthy performance for #Q4FY21;… https://t.co/Ej3k7bZEUj #SharekhanFNA #SharekhanResearch #Cadila #Q4FY21